MWPCG
ARMP icon

Measured Wealth Private Client Group’s Armata Pharmaceuticals ARMP Stock Holding History

Measured Wealth Private Client Group’s Portfolio ARMP Stock Details ARMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.2K Hold
1,000
– – ﹤0.01% 565
2025
Q4 		$6.28K Hold
1,000
– – ﹤0.01% 590
2025
Q3 		$2.98K Buy
+1,000
New +$2.59K ﹤0.01% 627

Other funds holding ARMP

MAM
Madison Asset Management Madison, Wisconsin $8.06B AUM 11.81% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Measured Wealth Private Client Group's ARMP Position: Q1 2026 in Review

Measured Wealth Private Client Group held its Armata Pharmaceuticals (ARMP) position steady in Q1 2026 at 1,000 shares worth $10.2K. The position accounts for ﹤0.01% of the portfolio, ranked #565.

Measured Wealth Private Client Group first reported a position in ARMP in Q3 2025 and has held it in 3 quarters since. 45 funds tracked by Wall St. Rank hold ARMP as of Q1 2026.

  • Measured Wealth Private Client Group held 1,000 shares of Armata Pharmaceuticals worth $10.2K as of Q1 2026.
  • Measured Wealth Private Client Group left its Armata Pharmaceuticals share count unchanged in Q1 2026.
  • Armata Pharmaceuticals made up ﹤0.01% of Measured Wealth Private Client Group's portfolio in Q1 2026, its #565 holding.
  • Measured Wealth Private Client Group first reported a position in Armata Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • 45 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q1 2026.

Based on Measured Wealth Private Client Group's 13F filing for Q1 2026, filed 13 May 2026.